|
業務類別
|
Biotechnology |
|
業務概覽
|
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). |
| 公司地址
| 901 Gateway Boulevard, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 808-6000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.theravance.com |
| 員工數量
| 97 |
| Ms. Rhonda Farnum |
Chief Business Officer and Senior Vice President, Commercial and Medical Affairs |
-- |
10/04/2025 |
| Mr. Aziz Sawaf, C.F.A. |
Senior Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 462.38K |
10/04/2025 |
| Dr. Aine Miller, PhD |
Senior Vice President, Development and Head, Ireland Office |
-- |
10/04/2025 |
| Mr. Rick E. Winningham |
Director and Chief Executive Officer |
美元 1.05M |
10/04/2025 |
| Mr. Brett A. Grimaud |
Senior Vice President, General Counsel and Secretary |
美元 480.87K |
10/04/2025 |
|
|
| Mr. Donal O’Connor |
Independent Director |
10/04/2025 |
| Dr. Laurie Smaldone Alsup, M.D. |
Independent Director |
10/04/2025 |
| Mr. Rick E. Winningham |
Director and Chief Executive Officer |
10/04/2025 |
| Dr. Deepika Rachel Pakianathan |
Independent Director |
10/04/2025 |
| Mr. Eran Broshy |
Independent Director |
10/04/2025 |
| Mr. Dean Jonathan Mitchell |
Independent Director |
10/04/2025 |
| Mr. James C. Kelly |
Independent Director |
10/04/2025 |
| Mr. Jeremy Grant |
Independent Director |
10/04/2025 |
| Ms. Susannah Gray, M.B.A. |
Chairman of the board |
10/04/2025 |
|
|
|
|
